To include your compound in the COVID-19 Resource Center, submit it here.

Bococizumab: Completed Phase III enrollment

Pfizer completed enrollment of about 10,600 patients in the double-blind, placebo-controlled, international Phase III

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE